請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58297
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 賴亮全(Liang - Chuan Lai),江福田(Fu - Tien Chiang) | |
dc.contributor.author | Jyh-Ming Jimmy Juang | en |
dc.contributor.author | 莊志明 | zh_TW |
dc.date.accessioned | 2021-06-16T08:10:38Z | - |
dc.date.available | 2019-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-03-21 | |
dc.identifier.citation | 1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992;20:1391-6.
2. Brugada P, Brugada R, Brugada J. The Brugada syndrome. Curr Cardiol Rep 2000;2:507-14. 3. Nademanee K, Veerakul G, Nimmannit S et al. Arrhythmogenic marker for the sudden unexplained death syndrome in Thai men. Circulation 1997;96:2595-600. 4. Wilde AA, Antzelevitch C, Borggrefe M et al. Proposed diagnostic criteria for the Brugada syndrome: consensus report. Circulation 2002;106:2514-9. 5. Atarashi H, Fujiwara T, Saito H, Hayakawa H, Okumura H. [Frequency of cardiac arrhythmias and age-related changes in a general hospital--report from Inada-Noborito Hospital in 1983]. Nippon Ronen Igakkai Zasshi 1986;23:41-9. 6. Katz LN, Pick A. Part 1 The Arrhythmias. Clinical Electrocardiography. Philadelphia: Lea & Febiger, 1956:40-4. 7. Hermida JS, Lemoine JL, Aoun FB, Jarry G, Rey JL, Quiret JC. Prevalence of the brugada syndrome in an apparently healthy population. Am J Cardiol 2000;86:91-4. 8. Gussak I, Antzelevitch C, Bjerregaard P, Towbin JA, Chaitman BR. The Brugada syndrome: clinical, electrophysiologic and genetic aspects. J Am Coll Cardiol 1999;33:5-15. 9. Tohyou Y, Nakazawa K, Ozawa A et al. A survey in the incidence of right bundle branch block with ST segment elevation among normal population. Jpn J Electrocardiol 1995;15:223-226. 10. Atarashi H, Ogawa S, Harumi K et al. Three-year follow-up of patients with right bundle branch block and ST segment elevation in the right precordial leads: Japanese Registry of Brugada Syndrome. Idiopathic Ventricular Fibrillation Investigators. J Am Coll Cardiol 2001;37:1916-20. 11. Miyasaka Y, Tsuji H, Yamada K et al. Prevalence and mortality of the Brugada-type electrocardiogram in one city in Japan. J Am Coll Cardiol 2001;38:771-4. 12. Camm AJ, Antzelevitch C, Brugada P et al. Clinical Approaches to Tachyarrhythmias. Armonk, N.Y.: Futura Publishing Company, Inc., 1999:10-5. 13. Goh KT, Chao TC, Chew CH. Sudden nocturnal deaths among Thai construction workers in Singapore. Lancet 1990;335:1154. 14. Monroe MH, Littmann L. Two-year case collection of the Brugada syndrome electrocardiogram pattern at a large teaching hospital. Clin Cardiol 2000;23:849-51. 15. Greer RW, Glancy DL. Prevalence of the Brugada electrocardiographic pattern at the Medical Center of Louisiana in New Orleans. J La State Med Soc 2003;155:242-6. 16. Viskin S, Fish R, Eldar M et al. Prevalence of the Brugada sign in idiopathic ventricular fibrillation and healthy controls. Heart 2000;84:31-6. 17. Furuhashi M, Uno K, Tsuchihashi K et al. Prevalence of asymptomatic ST segment elevation in right precordial leads with right bundle branch block (Brugada-type ST shift) among the general Japanese population. Heart 2001;86:161-6. 18. Matsuo K, Akahoshi M, Nakashima E et al. The prevalence, incidence and prognostic value of the Brugada-type electrocardiogram: a population-based study of four decades. J Am Coll Cardiol 2001;38:765-70. 19. Atarashi H, Ogawa S, Harumi K et al. Characteristics of patients with right bundle branch block and ST-segment elevation in right precordial leads. Idiopathic Ventricular Fibrillation Investigators. Am J Cardiol 1996;78:581-3. 20. Brugada J, Brugada R, Brugada P. Right bundle-branch block and ST-segment elevation in leads V1 through V3: a marker for sudden death in patients without demonstrable structural heart disease. Circulation 1998;97:457-60. 21. Priori SG, Napolitano C, Gasparini M et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: A prospective evaluation of 52 families. Circulation 2000;102:2509-15. 22. Priori SG, Napolitano C, Gasparini M et al. Natural history of Brugada syndrome: insights for risk stratification and management. Circulation 2002;105:1342-7. 23. Takenaka S, Kusano KF, Hisamatsu K et al. Relatively benign clinical course in asymptomatic patients with brugada-type electrocardiogram without family history of sudden death. J Cardiovasc Electrophysiol 2001;12:2-6. 24. Wilde A, Duren D. Sudden cardiac death, RBBB, and right precordial ST-segment elevation. Circulation 1999;99:722-3. 25. Galdas PM, Cheater F, Marshall P. Men and health help-seeking behaviour: literature review. J Adv Nurs 2005;49:616-23. 26. Tudiver F, Talbot Y. Why don't men seek help? Family physicians' perspectives on help-seeking behavior in men. J Fam Pract 1999;48:47-52. 27. Hermida JS, Lemoine JL, Aoun FB. Prevalence of the Brugada syndromein apparently healthy population. Am J Cardiol 2000;86:91-4. 28. Atarashi H, Ogawa S, Harumi K, et, al. Three-Year Follow-Up of Patients with Right Bundle Branch Block and ST Segment Elevation in the Right Precordial Leads:Japanese Registry of Brugada Syndrome. J Am Coll Cardiol 2001;37:1916-20. 29. Nademanee K. Sudden unexplained death syndrome in Southeast Asia. Am J Cardiol 1997;79:10-1. 30. Vatta M, Dumaine R, Varghese G et al. Genetic and biophysical basis of sudden unexplained nocturnal death syndrome (SUNDS), a disease allelic to Brugada syndrome. Hum Mol Genet 2002;11:337-45. 31. Brugada P, Brugada J, Brugada R. Arrhythmia induction by antiarrhythmic drugs. Pacing Clin Electrophysiol 2000;23:291-2. 32. Juang JM, Huang SK, Tsai CT et al. Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan. Cardiology 2003;99:182-9. 33. Chen Q, Kirsch GE, Zhang D et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998;392:293-6. 34. Alings M, Wilde A. 'Brugada' syndrome: clinical data and suggested pathophysiological mechanism. Circulation 1999;99:666-73. 35. Camm AJ. Clinical Approaches To Tachyarrhythmias: Futura Publishing Company, Inc, 1999. 36. Morita H, Nagase S, Kusano K, Ohe T. Spontaneous T wave alternans and premature ventricular contractions during febrile illness in a patient with Brugada syndrome. J Cardiovasc Electrophysiol 2002;13:816-8. 37. Nagase S, Kusano KF, Morita H et al. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol 2002;39:1992-5. 38. Bordachar P, Reuter S, Garrigue S et al. Incidence, clinical implications and prognosis of atrial arrhythmias in Brugada syndrome. Eur Heart J 2004;25:879-84. 39. Probst V, Allouis M, Sacher F et al. Progressive cardiac conduction defect is the prevailing phenotype in carriers of a Brugada syndrome SCN5A mutation. J Cardiovasc Electrophysiol 2006;17:270-5. 40. Bigi MA, Aslani A. Significance of cardiac autonomic neuropathy in risk stratification of Brugada syndrome. Europace 2008;10:821-4. 41. Wilde AA, Antzelevitch C, Borggrefe M et al. Proposed diagnostic criteria for the Brugada syndrome. European heart journal 2002;23:1648-54. 42. Antzelevitch C, Brugada P, Borggrefe M et al. Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005;111:659-70. 43. Antzelevitch C, Brugada P, Borggrefe M et al. Brugada syndrome: report of the second consensus conference. Heart Rhythm 2005;2:429-40. 44. Wang Q, Li Z, Shen J, Keating MT. Genomic organization of the human SCN5A gene encoding the cardiac sodium channel. Genomics 1996;34:9-16. 45. Juang JM, Phan WL, Chen PC et al. Brugada-type electrocardiogram in the Taiwanese population--is it a risk factor for sudden death? J Formos Med Assoc 2011;110:230-8. 46. Ackerman MJ, Priori SG, Willems S et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011;13:1077-109. 47. Kapplinger JD, Tester DJ, Alders M et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010;7:33-46. 48. Mizusawa Y, Wilde AA. Brugada syndrome. Circulation Arrhythmia and electrophysiology 2012;5:606-16. 49. Berne P, Brugada J. Brugada syndrome 2012. Circ J 2012;76:1563-71. 50. Hsueh CH, Chen WP, Lin JL et al. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations. Journal of biomedical science 2009;16:23. 51. Wei Q, Wang L, Wang Q, Kruger WD, Dunbrack RL, Jr. Testing computational prediction of missense mutation phenotypes: functional characterization of 204 mutations of human cystathionine beta synthase. Proteins 2010;78:2058-74. 52. Teng S, Michonova-Alexova E, Alexov E. Approaches and resources for prediction of the effects of non-synonymous single nucleotide polymorphism on protein function and interactions. Curr Pharm Biotechnol 2008;9:123-33. 53. Schwartz CE, Chen CF. Progress in detecting genetic alterations and their association with human disease. J Mol Biol 2013;425:3914-8. 54. Budny B, Badura-Stronka M, Materna-Kiryluk A et al. Novel missense mutations in the ubiquitination-related gene UBE2A cause a recognizable X-linked mental retardation syndrome. Clin Genet 2010;77:541-51. 55. Daoud H, Valdmanis PN, Kabashi E et al. Contribution of TARDBP mutations to sporadic amyotrophic lateral sclerosis. J Med Genet 2009;46:112-4. 56. Tischkowitz MD, Yilmaz A, Chen LQ et al. Identification and characterization of novel SNPs in CHEK2 in Ashkenazi Jewish men with prostate cancer. Cancer Lett 2008;270:173-80. 57. Stefl S, Nishi H, Petukh M, Panchenko AR, Alexov E. Molecular mechanisms of disease-causing missense mutations. J Mol Biol 2013;425:3919-36. 58. Zhang Z, Teng S, Wang L, Schwartz CE, Alexov E. Computational analysis of missense mutations causing Snyder-Robinson syndrome. Hum Mutat 2010;31:1043-9. 59. Zhang Z, Norris J, Kalscheuer V et al. A Y328C missense mutation in spermine synthase causes a mild form of Snyder-Robinson syndrome. Hum Mol Genet 2013;22:3789-97. 60. Boccuto L, Aoki K, Flanagan-Steet H et al. A mutation in a ganglioside biosynthetic enzyme, ST3GAL5, results in salt & pepper syndrome, a neurocutaneous disorder with altered glycolipid and glycoprotein glycosylation. Hum Mol Genet 2013. 61. Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc 2009;4:1073-81. 62. Adzhubei IA, Schmidt S, Peshkin L et al. A method and server for predicting damaging missense mutations. Nat Methods 2010;7:248-9. 63. Tavtigian SV, Deffenbaugh AM, Yin L et al. Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral. J Med Genet 2006;43:295-305. 64. Mathe E, Olivier M, Kato S, Ishioka C, Hainaut P, Tavtigian SV. Computational approaches for predicting the biological effect of p53 missense mutations: a comparison of three sequence analysis based methods. Nucleic Acids Res 2006;34:1317-25. 65. Yang ZR, Thomson R, McNeil P, Esnouf RM. RONN: the bio-basis function neural network technique applied to the detection of natively disordered regions in proteins. Bioinformatics 2005;21:3369-76. 66. Kelley LA, Sternberg MJ. Protein structure prediction on the Web: a case study using the Phyre server. Nat Protoc 2009;4:363-71. 67. Chen PC, Chen YC, Lai LC et al. Use of germline polymorphisms in predicting concurrent chemoradiotherapy response in esophageal cancer. Int J Radiat Oncol Biol Phys 2012;82:1996-2003. 68. Kapa S, Tester DJ, Salisbury BA et al. Genetic testing for long-QT syndrome: distinguishing pathogenic mutations from benign variants. Circulation 2009;120:1752-60. 69. Karolchik D, Hinrichs AS, Kent WJ. The UCSC Genome Browser. Curr Protoc Bioinformatics 2007;Chapter 1:Unit 1 4. 70. Cooper GM, Stone EA, Asimenos G, Green ED, Batzoglou S, Sidow A. Distribution and intensity of constraint in mammalian genomic sequence. Genome Res 2005;15:901-13. 71. Poelzing S, Forleo C, Samodell M et al. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation 2006;114:368-76. 72. Ackerman MJ, Splawski I, Makielski JC et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004;1:600-7. 73. Tan BH, Valdivia CR, Rok BA et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005;2:741-7. 74. Hwang HW, Chen JJ, Lin YJ et al. R1193Q of SCN5A, a Brugada and long QT mutation, is a common polymorphism in Han Chinese. J Med Genet 2005;42:e7; author reply e8. 75. Huang H, Zhao J, Barrane FZ, Champagne J, Chahine M. Nav1.5/R1193Q polymorphism is associated with both long QT and Brugada syndromes. Can J Cardiol 2006;22:309-13. 76. Fu W, O'Connor TD, Jun G et al. Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 2013;493:216-20. 77. Ackerman MJ, Splawski I, Makielski JC et al. Spectrum and prevalence of cardiac sodium channel variants among black, white, Asian, and Hispanic individuals: implications for arrhythmogenic susceptibility and Brugada/long QT syndrome genetic testing. Heart Rhythm 2004;1:600-7. 78. Tan BH, Valdivia CR, Rok BA et al. Common human SCN5A polymorphisms have altered electrophysiology when expressed in Q1077 splice variants. Heart Rhythm 2005;2:741-7. 79. Takahata T, Yasui-Furukori N, Sasaki S et al. Nucleotide changes in the translated region of SCN5A from Japanese patients with Brugada syndrome and control subjects. Life Sci 2003;72:2391-9. 80. Wang Q, Chen S, Chen Q et al. The common SCN5A mutation R1193Q causes LQTS-type electrophysiological alterations of the cardiac sodium channel. Journal of medical genetics 2004;41:e66. 81. Kapplinger JD, Tester DJ, Alders M et al. An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing. Heart Rhythm 2010;7:33-46. 82. Marchler-Bauer A, Lu S, Anderson JB et al. CDD: a Conserved Domain Database for the functional annotation of proteins. Nucleic acids research 2011;39:D225-9. 83. Choe S. Potassium channel structures. Nat Rev Neurosci 2002;3:115-21. 84. Bateman A, Coggill P, Finn RD. DUFs: families in search of function. Acta Crystallogr Sect F Struct Biol Cryst Commun 2010;66:1148-52. 85. Arnold K, Bordoli L, Kopp J, Schwede T. The SWISS-MODEL workspace: a web-based environment for protein structure homology modelling. Bioinformatics 2006;22:195-201. 86. Zhang ZS, Tranquillo J, Neplioueva V, Bursac N, Grant AO. Sodium channel kinetic changes that produce Brugada syndrome or progressive cardiac conduction system disease. Am J Physiol Heart Circ Physiol 2007;292:H399-407. 87. Gutter C, Benndorf K, Zimmer T. Characterization of N-terminally mutated cardiac Na(+) channels associated with long QT syndrome 3 and Brugada syndrome. Front Physiol 2013;4:153. 88. Makita N, Sasaki K, Groenewegen WA et al. Congenital atrial standstill associated with coinheritance of a novel SCN5A mutation and connexin 40 polymorphisms. Heart Rhythm 2005;2:1128-34. 89. Pfahnl AE, Viswanathan PC, Weiss R et al. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm 2007;4:46-53. 90. Tarradas A, Selga E, Beltran-Alvarez P et al. A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome. PLoS One 2013;8:e53220. 91. Keller DI, Huang H, Zhao J et al. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovasc Res 2006;70:521-9. 92. Deschenes I, Baroudi G, Berthet M et al. Electrophysiological characterization of SCN5A mutations causing long QT (E1784K) and Brugada (R1512W and R1432G) syndromes. Cardiovasc Res 2000;46:55-65. 93. Akai J, Makita N, Sakurada H et al. A novel SCN5A mutation associated with idiopathic ventricular fibrillation without typical ECG findings of Brugada syndrome. FEBS Lett 2000;479:29-34. 94. Meregalli PG, Ruijter JM, Hofman N, Bezzina CR, Wilde AA, Tan HL. Diagnostic value of flecainide testing in unmasking SCN5A-related Brugada syndrome. J Cardiovasc Electrophysiol 2006;17:857-64. 95. Nishii N, Ogawa M, Morita H et al. SCN5A mutation is associated with early and frequent recurrence of ventricular fibrillation in patients with Brugada syndrome. Circ J 2010;74:2572-8. 96. Juang J-MJ, Tsai C-T, Lin L-Y et al. Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan. Journal of the Formosan Medical Association 2013;in press; http://dx.doi.org/10.1016/j.jfma.2013.02.002. 97. Gehi AK, Duong TD, Metz LD, Gomes JA, Mehta D. Risk stratification of individuals with the Brugada electrocardiogram: a meta-analysis. J Cardiovasc Electrophysiol 2006;17:577-83. 98. Junttila MJ, Brugada P, Hong K et al. Differences in 12-lead electrocardiogram between symptomatic and asymptomatic Brugada syndrome patients. J Cardiovasc Electrophysiol 2008;19:380-3. 99. Probst V, Veltmann C, Eckardt L et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation 2010;121:635-43. 100. Jyh-Ming Jimmy Juang T-PL, Liang-Chuan Lai, Chia-Hsiang Hsueh, Yen-Bin Liu, Chia-Ti Tsai,, Lian-Yu Lin C-CY, Juey-Jen Hwang, Fu-Tien Chiang, Sherri Shih-Fan Yeh, Wen-Pin Chen,, Eric Y. Chuang L-PL, Jiunn-Lee Lin. Utilizing Multiple in Silico Analyses to Identify Putative Causal SCN5A Variants in Brugada Syndrome. Scientific Reports 2014;4 : 3850 | DOI: 10.1038/srep03850. 101. Zareba W, Moss AJ, Schwartz PJ et al. Influence of genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. N Engl J Med 1998;339:960-5. 102. Eckardt L, Probst V, Smits JP et al. Long-term prognosis of individuals with right precordial ST-segment-elevation Brugada syndrome. Circulation 2005;111:257-63. 103. Brugada J, Brugada R, Antzelevitch C, Towbin J, Nademanee K, Brugada P. Long-term follow-up of individuals with the electrocardiographic pattern of right bundle-branch block and ST-segment elevation in precordial leads V1 to V3. Circulation 2002;105:73-8. 104. Crotti L, Marcou CA, Tester DJ et al. Spectrum and prevalence of mutations involving BrS1- through BrS12-susceptibility genes in a cohort of unrelated patients referred for Brugada syndrome genetic testing: implications for genetic testing. J Am Coll Cardiol 2012;60:1410-8. 105. Pollex RL, Hegele RA. Copy number variation in the human genome and its implications for cardiovascular disease. Circulation 2007;115:3130-8. 106. Soemedi R, Wilson IJ, Bentham J et al. Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet 2012;91:489-501. 107. Li L, Krantz ID, Deng Y et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997;16:243-51. 108. Barc J, Briec F, Schmitt S et al. Screening for copy number variation in genes associated with the long QT syndrome: clinical relevance. J Am Coll Cardiol 2011;57:40-7. 109. Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature 2006;444:444-54. 110. Jeong EM, Liu M, Sturdy M et al. Metabolic stress, reactive oxygen species, and arrhythmia. Journal of molecular and cellular cardiology 2012;52:454-63. 111. Sovari AA, Rutledge CA, Jeong EM et al. Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death. Circulation Arrhythmia and electrophysiology 2013;6:623-31. 112. Lu B, Su Y, Das S, Liu J, Xia J, Ren D. The neuronal channel NALCN contributes resting sodium permeability and is required for normal respiratory rhythm. Cell 2007;129:371-83. 113. Milan DJ, Macrae CA. Zebrafish genetic models for arrhythmia. Progress in biophysics and molecular biology 2008;98:301-8. 114. Milan DJ, Jones IL, Ellinor PT, MacRae CA. In vivo recording of adult zebrafish electrocardiogram and assessment of drug-induced QT prolongation. Am J Physiol Heart Circ Physiol 2006;291:H269-73. 115. Lu TP, Lai LC, Tsai MH et al. Integrated analyses of copy number variations and gene expression in lung adenocarcinoma. PLoS One 2011;6:e24829. 116. Pruitt KD, Tatusova T, Klimke W, Maglott DR. NCBI Reference Sequences: current status, policy and new initiatives. Nucleic Acids Res 2009;37:D32-6. 117. Gamazon ER, Zhang W, Konkashbaev A et al. SCAN: SNP and copy number annotation. Bioinformatics 2010;26:259-62. 118. Iafrate AJ, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat Genet 2004;36:949-51. 119. Shaikh TH, Gai X, Perin JC et al. High-resolution mapping and analysis of copy number variations in the human genome: a data resource for clinical and research applications. Genome Res 2009;19:1682-90. 120. Koike A, Nishida N, Inoue I, Tsuji S, Tokunaga K. Genome-wide association database developed in the Japanese Integrated Database Project. J Hum Genet 2009;54:543-6. 121. Dickens NJ, Walker BA, Leone PE et al. Homozygous deletion mapping in myeloma samples identifies genes and an expression signature relevant to pathogenesis and outcome. Clin Cancer Res 2010;16:1856-64. 122. Gunnarsson R, Mansouri L, Isaksson A et al. Array-based genomic screening at diagnosis and during follow-up in chronic lymphocytic leukemia. Haematologica 2011;96:1161-9. 123. Matsuyama Y, Suzuki M, Arima C et al. Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomas. Mol Carcinog 2011;50:301-9. 124. Hu N, Wang C, Ng D et al. Genomic characterization of esophageal squamous cell carcinoma from a high-risk population in China. Cancer Res 2009;69:5908-17. 125. Kim JC, Kim SY, Cho DH et al. Novel chemosensitive single-nucleotide polymorphism markers to targeted regimens in metastatic colorectal cancer. Clin Cancer Res 2011;17:1200-9. 126. Yamada K, Iwayama Y, Hattori E et al. Genome-wide association study of schizophrenia in Japanese population. PLoS One 2011;6:e20468. 127. Shaw JA, Page K, Blighe K et al. Genomic analysis of circulating cell-free DNA infers breast cancer dormancy. Genome Res 2012;22:220-31. 128. Chen YH, Pai CW, Huang SW et al. Inactivation of Myosin binding protein C homolog in zebrafish as a model for human cardiac hypertrophy and diastolic dysfunction. Journal of the American Heart Association 2013;2:e000231. 129. Matthews M, Varga ZM. Anesthesia and euthanasia in zebrafish. ILAR journal / National Research Council, Institute of Laboratory Animal Resources 2012;53:192-204. 130. Kimmel CB, Ballard WW, Kimmel SR, Ullmann B, Schilling TF. Stages of embryonic development of the zebrafish. Developmental dynamics : an official publication of the American Association of Anatomists 1995;203:253-310. 131. Tsai CT, Chiang FT, Tseng CD et al. Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation. J Am Coll Cardiol 2010;55:758-70. 132. Tsai CT, Lai LP, Kuo KT et al. Angiotensin II activates signal transducer and activators of transcription 3 via Rac1 in atrial myocytes and fibroblasts: implication for the therapeutic effect of statin in atrial structural remodeling. Circulation 2008;117:344-55. 133. Tsai CT, Chiang FT, Tseng CD et al. Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans. J Am Coll Cardiol 2011;58:2106-15. 134. Claycomb WC, Lanson NA, Jr., Stallworth BS et al. HL-1 cells: a cardiac muscle cell line that contracts and retains phenotypic characteristics of the adult cardiomyocyte. Proc Natl Acad Sci U S A 1998;95:2979-84. 135. Stephenson EA, Berul CI. Electrophysiological interventions for inherited arrhythmia syndromes. Circulation 2007;116:1062-80. 136. Weaver S, Dube S, Mir A et al. Taking qPCR to a higher level: Analysis of CNV reveals the power of high throughput qPCR to enhance quantitative resolution. Methods 2010;50:271-6. 137. Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001;12:268-72. 138. Napolitano C, Antzelevitch C. Phenotypical manifestations of mutations in the genes encoding subunits of the cardiac voltage-dependent L-type calcium channel. Circ Res 2011;108:607-18. 139. Antzelevitch C, Pollevick GD, Cordeiro JM et al. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation 2007;115:442-9. 140. Burashnikov E, Pfeiffer R, Barajas-Martinez H et al. Mutations in the cardiac L-type calcium channel associated with inherited J-wave syndromes and sudden cardiac death. Heart Rhythm 2010;7:1872-82. 141. Cordeiro JM, Marieb M, Pfeiffer R, Calloe K, Burashnikov E, Antzelevitch C. Accelerated inactivation of the L-type calcium current due to a mutation in CACNB2b underlies Brugada syndrome. Journal of molecular and cellular cardiology 2009;46:695-703. 142. Hentze MW, Kulozik AE. A perfect message: RNA surveillance and nonsense-mediated decay. Cell 1999;96:307-10. 143. Hayes JD, McLellan LI. Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress. Free radical research 1999;31:273-300. 144. Lee JH, Cribbs LL, Perez-Reyes E. Cloning of a novel four repeat protein related to voltage-gated sodium and calcium channels. FEBS letters 1999;445:231-6. 145. Uhlen M, Oksvold P, Fagerberg L et al. Towards a knowledge-based Human Protein Atlas. Nat Biotechnol 2010;28:1248-50. 146. Hong K, Guerchicoff A, Pollevick GD et al. Cryptic 5' splice site activation in SCN5A associated with Brugada syndrome. Journal of molecular and cellular cardiology 2005;38:555-60. 147. Jensen LJ, Kuhn M, Stark M et al. STRING 8--a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009;37:D412-6. 148. Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D. GeneCards: integrating information about genes, proteins and diseases. Trends Genet 1997;13:163. 149. Hedley PL, Jorgensen P, Schlamowitz S et al. The genetic basis of long QT and short QT syndromes: a mutation update. Hum Mutat 2009;30:1486-511. 150. Wilders R, Verkerk AO. Role of the R1135H KCNH2 mutation in Brugada syndrome. Int J Cardiol 2010;144:149-51. 151. Kubota T, Horie M, Takano M et al. Evidence for a single nucleotide polymorphism in the KCNQ1 potassium channel that underlies susceptibility to life-threatening arrhythmias. J Cardiovasc Electrophysiol 2001;12:1223-9. 152. O'Neill BT, Abel ED. Akt1 in the cardiovascular system: friend or foe? J Clin Invest 2005;115:2059-64. 153. Shiojima I, Sato K, Izumiya Y et al. Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. J Clin Invest 2005;115:2108-18. 154. Pereira VH, Cerqueira JJ, Palha JA, Sousa N. Stressed brain, diseased heart: a review on the pathophysiologic mechanisms of neurocardiology. Int J Cardiol 2013;166:30-7. 155. Davis AM, Natelson BH. Brain-heart interactions. The neurocardiology of arrhythmia and sudden cardiac death. Texas Heart Institute journal / from the Texas Heart Institute of St Luke's Episcopal Hospital, Texas Children's Hospital 1993;20:158-69. 156. Lown B, Verrier RL, Rabinowitz SH. Neural and psychologic mechanisms and the problem of sudden cardiac death. Am J Cardiol 1977;39:890-902. 157. Altman DG, Bland JM. Diagnostic tests 2: Predictive values. BMJ 1994;309:102. 158. Delpon E, Cordeiro JM, Nunez L et al. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circulation Arrhythmia and electrophysiology 2008;1:209-18. 159. Giudicessi JR, Ye D, Tester DJ et al. Transient outward current (I(to)) gain-of-function mutations in the KCND3-encoded Kv4.3 potassium channel and Brugada syndrome. Heart Rhythm 2011;8:1024-32. 160. Medeiros-Domingo A, Tan BH, Crotti L et al. Gain-of-function mutation S422L in the KCNJ8-encoded cardiac K(ATP) channel Kir6.1 as a pathogenic substrate for J-wave syndromes. Heart Rhythm 2010;7:1466-71. 161. Veerakul G, Nademanee K. Brugada syndrome: two decades of progress. Circ J 2012;76:2713-22. 162. Lund AK, Goens MB, Kanagy NL, Walker MK. Cardiac hypertrophy in aryl hydrocarbon receptor null mice is correlated with elevated angiotensin II, endothelin-1, and mean arterial blood pressure. Toxicology and applied pharmacology 2003;193:177-87. 163. Alias L, Bernal S, Barcelo MJ et al. Accuracy of marker analysis, quantitative real-time polymerase chain reaction, and multiple ligation-dependent probe amplification to determine SMN2 copy number in patients with spinal muscular atrophy. Genetic testing and molecular biomarkers 2011;15:587-94. 164. O'Sullivan J, Mullaney BG, Bhaskar SS et al. A paradigm shift in the delivery of services for diagnosis of inherited retinal disease. J Med Genet 2012;49:322-6. 165. Valencia CA, Ankala A, Rhodenizer D et al. Comprehensive mutation analysis for congenital muscular dystrophy: a clinical PCR-based enrichment and next-generation sequencing panel. PloS one 2013;8:e53083. 166. Rehm HL. Disease-targeted sequencing: a cornerstone in the clinic. Nature reviews Genetics 2013;14:295-300. 167. Hedley PL, Jorgensen P, Schlamowitz S et al. The genetic basis of Brugada syndrome: a mutation update. Hum Mutat 2009;30:1256-66. 168. Van Norstrand DW, Valdivia CR, Tester DJ et al. Molecular and functional characterization of novel glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-L) mutations in sudden infant death syndrome. Circulation 2007;116:2253-9. 169. Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One 2012;7:e46688. 170. Li B, Krishnan VG, Mort ME et al. Automated inference of molecular mechanisms of disease from amino acid substitutions. Bioinformatics 2009;25:2744-50. 171. Pollard KS, Hubisz MJ, Rosenbloom KR, Siepel A. Detection of nonneutral substitution rates on mammalian phylogenies. Genome Res 2010;20:110-21. 172. Szklarczyk D, Franceschini A, Kuhn M et al. The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res 2011;39:D561-8. 173. Abecasis GR, Auton A, Brooks LD et al. An integrated map of genetic variation from 1,092 human genomes. Nature 2012;491:56-65. 174. Heron SE, Smith KR, Bahlo M et al. Missense mutations in the sodium-gated potassium channel gene KCNT1 cause severe autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet 2012;44:1188-90. 175. Harrell MD, Harbi S, Hoffman JF, Zavadil J, Coetzee WA. Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. Physiol Genomics 2007;28:273-83. 176. Sato A, Sekine Y, Saruta C et al. Cerebellar development transcriptome database (CDT-DB): profiling of spatio-temporal gene expression during the postnatal development of mouse cerebellum. Neural networks : the official journal of the International Neural Network Society 2008;21:1056-69. 177. Riepe FG. Clinical and molecular features of type 1 pseudohypoaldost | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58297 | - |
dc.description.abstract | 布魯蓋達症候群(Brugada syndrome, BrS)是一種突發性心臟性猝死(Sudden cardiac death, SCD)的疾病。流行病學研究顯示,本病可能是將近一半的突發性無器質性心臟疾病死亡的原因。這種疾病也是東南亞年輕人猝死最常見的原因。因此,我們進行了一系列的BrS研究,包括流行病學,臨床和遺傳表現,電腦程式的預測應用分析,帶有SCN5A基因突變BrS患者的長期預後分析,拷貝數變異(Copy Number Variation)和利用新一代定序(Next-Generation Sequencing)找尋新的BrS致病基因 。我們發現帶Brugada型心電圖患者並不少見。帶Brugada型心電圖患者若無暈厥或心臟猝死病史。我們分析台灣最大的BrS世代的SCN5A基因突變發生率。SCN5A基因突變的發生率顯著低於高加索人群。我們開發了一種新的方法通過組合多個電腦程式進行分析,在進行體外研究(in vitro)之前預測SCN5A基因可疑變異在BrS中的功能和結構變化。我們的結論是整合突變序列信息和預測蛋白質二級結構分子可於進行耗時的電生理研究前,幫助篩選極具可能變異的 BrS SCN5A突變位點。回到臨床,我們前瞻性地研究結論是SCN5A突變可能不是預測有症狀的BrS患者復發性心律失常事件的因子,而是心律失常事件的發生時間的預測因子。在進階的基因研究,我們在非家族性有症狀且沒有SCN5A基因變異的BrS患者身上發現兩種新的拷貝數缺失(GSTM3和NALCN),這表示篩檢CNV可以幫助診斷和預測SCN5A基因變異陰性患者的BrS 。另外,利用新一代定序找尋新的BrS致病基因,我們在15個無相關,非家族的BrS患者且沒有SCN5A基因突變或單核苷酸多態性進行疾病為導向多基因定序,包括130人離子通道的基因和12已報導的BrS基因。在三個BrS患者的四個基因( SCNN1A , KCNJ16 , KCNB2和KCNT1 )找到五個新的BrS致病突變。
從上面的研究結果,我們提供臺灣的BrS更深入的資料。 BrS在台灣並不少見,在台灣的BrS患者SCN5A基因突變的比例比在高加索人群要低得多。我們也發現幾個新的CNV或新的BrS致病突變值得進一步研究,以深入探討BrS致病機制。 | zh_TW |
dc.description.abstract | Brugada syndrome (BrS) is a hereditable sudden cardiac death (SCD) disease. Epidemiologic studies suggest that the disease might be responsible for nearly half of all sudden cardiac deaths in individuals without structural heart diseases. This disease is the most common cause of SCD in young persons in South Asia including Taiwan. As a result, we conducted a series of studies on BrS regarding epidemiology, clinical and genetic presentations, application of in silico analyses, long-term prognosis of BrS patients with SCN5A mutation, copy number variations and identification of novel genes using next-generation sequencing in BrS. We found that patients with Brugada-type ECGs are not rare in a hospital-based population. We investigated the prevalence of SCN5A mutation in the largest BrS cohort in Taiwan. The prevalence of SCN5A mutations was significantly lower than 20–25% in Caucasian populations. We developed a new approach by combining multiple in silico analyses to predict functional and structural changes of candidate SCN5A variants in BrS before conducting in vitro studies. Back to clinical implication, we prospectively investigated the recurrent events of symptomatic BrS patients with/without SCN5A mutations and concluded that SCN5A mutations may be not a predictor of recurrent arrhythmic events in symptomatic BrS patients, but a predictor of the timing of the onset of first cardiac event. In advanced genetic studies, we identifed two novel deletions in GSTM3 and NALCN in non-familial symptomatic BrS patients without SCN5A variants and five de novo mutations in four genes (SCNN1A, KCNJ16, KCNB2, and KCNT1).
With the findings from the above serial studies, we have had an more advanced understanding about BrS. BrS is not uncommon in Taiwanese population. Several novel CNVs or de novo BrS-causative genes were identified in our BrS patients that deserved for further studies to investigate the underlying mechanisms of development of BrS. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:10:38Z (GMT). No. of bitstreams: 1 ntu-103-D99441003-1.pdf: 4081220 bytes, checksum: 1922b366fedfdba10dee4ffed53ac4e9 (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | Committee approval i
List of Tables v List of Figures vii Acknowledgement 1 中文摘要 2 Abstract 3 General Introduction 5 Chapter 1 Brugada-Type Electrocardiogram in the Taiwanese 7 Population—Is it a Risk Factor for Sudden Death? 7 Introduction 7 Methods 7 Results 10 Discussion 12 References 16 Tables 19 Figures 23 Chapter 2 Unique Clinical Characteristics and SCN5A Mutations in Patients with Brugada Syndrome in Taiwan 27 Introduction 27 Methods 28 Results 31 Discussion 33 References 38 Tables 40 Figures 43 Supplementary Tables 46 Chapter 3 Utilizing Multiple in Silico Analyses to Identify Putative Causal SCN5A Variants in Brugada Syndrome 48 Introduction 48 Methods 49 Results 53 Discussion 58 References 63 Tables 66 Figures 70 Supplementary Methods 74 Supplementary Tables 78 Supplementary Figure 80 Supplementary references 81 Chapter 4 Predictive Values of SCN5A Mutations in Patients with Symptomatic Brugada Syndrome: Long-term Follow-up (COBRA_ChiP Study) 83 Introduction 83 Methods 85 Results 88 Discussion 93 References 99 Tables 102 Figures 104 Chapter 5 Novel Copy Number Variants in SCN5A Variant-Negative Patients with Brugada Syndrome 108 Introduction 108 Methods 111 Results 116 Discussion 123 References 129 Tables 135 Figures 138 Supplementary Materials 144 Methods 144 Supplementary Tables 147 Supplementary Figures 151 Chapter 6 Disease-Targeted Sequencing of Genes Associated with Ion Channels identifies de novo mutations in Patients with Non-Familial Brugada Syndrome 154 Introduction 154 Methods 156 Results 160 Discussion 165 References 169 Tables 172 Figures 176 Clinical Implications and Future works 180 Conclusions 181 | |
dc.language.iso | en | |
dc.title | 布魯蓋達症候群--從臨床到基礎研究 | zh_TW |
dc.title | Study on Brugada Syndrome--From Bedside to Bench | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 曾春典,曾淵如,莊曜宇 | |
dc.subject.keyword | 布魯蓋達症候群,突發性心臟性猝死, | zh_TW |
dc.subject.keyword | Brugada-type ECG,sudden cardiac death,all-cause mortality,brugada syndrome,SCN5A mutations,Long-term prognosis,sodium channael,copy number variations,Next-generation sequencing,in silico analysis, | en |
dc.relation.page | 181 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-03-21 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 生理學研究所 | zh_TW |
顯示於系所單位: | 生理學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 3.99 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。